Profound Medical Corp.
PROF | NASDAQ
$6.12
+$0.02 (+0.33%)
Sep 22, 2026, 12:21 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -5.50 | -7.02 | -6.29 | -7.89 | -7.49 | -16.45 |
PEG Ratio | -0.16 | 0.34 | 2.89 | 0.99 | -0.37 | 1.63 |
PS Ratio | 14.53 | 18.29 | 24.98 | 33.95 | 33.44 | 48.68 |
PB Ratio | 2.61 | 3.08 | 5.76 | 4.36 | 2.85 | 3.65 |
P/FCF Ratio | -6.09 | -7.93 | -7.95 | -8.79 | -10.01 | -16.99 |
P/OCF Ratio | -6.12 | -7.93 | -7.95 | -8.79 | -10.28 | -17.28 |
OCF/S Ratio | -237.34 | -230.67 | -314.06 | -386.17 | -325.33 | -281.68 |
Debt / Equity Ratio | 0.07 | 0.08 | 0.25 | 0.16 | 0.02 | 0.02 |
Quick Ratio | 11.17 | 9.64 | 5.48 | 12.92 | 16.78 | 19.22 |
Current Ratio | 12.52 | 10.52 | 6.58 | 14.82 | 18.56 | 20.32 |
Asset Turnover | 0.08 | 0.14 | 0.16 | 0.10 | 0.08 | 0.07 |
Interest Coverage | n/a | n/a | -37.16 | -192.25 | -456.12 | -34.74 |
Return on Equity | -47.60% | -43.83% | -91.50% | -55.13% | -38.13% | -22.21% |
Return on Assets | -22.45% | -37.70% | -64.99% | -44.50% | -35.43% | -20.67% |
Return on Invested Capital | -22.70% | -47.93% | -71.31% | -52.67% | -36.60% | -18.84% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 70.77% | 65.89% | 60.87% | 45.22% | 42.95% | 47.56% |
Net Profit Margin | -264.44% | -260.45% | -396.85% | -429.11% | -446.66% | -296.03% |
Pretax Profit Margin | -262.88% | -260.47% | -398.62% | -424.82% | -445.13% | -295.41% |
Operating Profit Margin | -256.27% | -309.57% | -397.50% | -480.86% | -440.72% | -258.26% |
FCF Margin | -238.43% | -230.67% | -314.06% | -386.17% | -333.96% | -286.47% |
EBITDA Margin | -252.79% | -251.70% | -372.01% | -398.20% | -416.82% | -266.92% |
Add to Watchlist
Select watchlists to add or remove PROF